Liver Cancer Treatment Overview

Liver Cancer

Treatment Overview

CyberKnife® Robotic Radiosurgery is a non-invasive1 treatment for cancerous and non-cancerous tumors and conditions where radiation therapy is indicated.

The CyberKnife System is routinely used to treat liver cancers with a procedure called stereotactic body radiation therapy (SBRT). CyberKnife SBRT may be used to treat complicated cases, sparing healthy liver tissue and nearby organs from radiation exposure.

Introduction to the CyberKnife M6 System

Clinical publications related to CyberKnife treatment cases Despite its name, CyberKnife treatment is not a surgical procedure. In fact, there is no cutting involved. The CyberKnife System delivers radiation with the high level of precision required for SBRT. Radiation oncologists use the CyberKnife System when more invasive techniques are deemed inappropriate or too risky. CyberKnife treatment may be suited for patients who cannot undergo surgical procedures as a result of:

  • Location or size of the tumor
  • Patient's health
  • Previous surgery or radiotherapy
  • Desire to avoid surgery

The CyberKnife System was cleared by the U.S. Food and Drug Administration in 1999 to treat targets in the head and base of the skull, and in 2001 for treatment outside of the skull. Since then, thousands of patients have been treated with CyberKnife SBRT for conditions within the liver.

1. Radiation therapy is completely non-invasive. In some cases, tiny gold markers (fiducials) that help distinguish the tumor from non-cancerous soft tissue are implanted with a minimally invasive procedure.